Panaroma Central Station Product Usage: This device can view real time, store, print, graph...

FDA Device Recall #Z-1156-2014 — Class II — January 8, 2014

Recall Summary

Recall Number Z-1156-2014
Classification Class II — Moderate risk
Date Initiated January 8, 2014
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Mindray DS USA, Inc. dba Mindray North America
Location Mahwah, NJ
Product Type Devices
Quantity 732 units in the US

Product Description

Panaroma Central Station Product Usage: This device can view real time, store, print, graph, and trend patient clinical and demographic data. The device can also set independent alarm limits for data send by the bedside monitor.

Reason for Recall

Mindray has identified two issues with the Panorama Central Station. Full Disclosure data may lag behind the Panorama system time clock when the Panorama Central Station is in use with Mindray¿s V-Series Monitor. Additionally, event indicators lag behind the Panorama system time clock when the Panorama Central Station is in use with a Panorama Telepack.

Distribution Pattern

Worldwide Distribution - USA Nationwide Distribution

Lot / Code Information

p/n 0998-00-0708-01; 0998-UC-0708-01 and 0020-00-0205-XXX

Other Recalls from Mindray DS USA, Inc. dba Mindray Nort...

Recall # Classification Product Date
Z-0920-2026 Class II Hardware configuration of the BeneVision Centra... Nov 18, 2025
Z-0720-2026 Class II Sevoflurane (SEVO) V90 Electronic Vaporizer wit... Oct 20, 2025
Z-0721-2026 Class II Isoflurane (ISO) V90 Electronic Vaporizer with ... Oct 20, 2025
Z-2622-2025 Class II BeneVision N1 Patient Monitor (N1). Part Number... Aug 15, 2025
Z-2951-2024 Class II Isoflurane E_Vap.(Safety Filling adapter): used... Jul 22, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.